Penserra Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-130
| Closed | -$23K | – | 1063 |
|
|
2024
Q4 | $23K | Buy |
+130
| New | +$23K | ﹤0.01% | 1006 |
|
|
2024
Q1 | – | Sell |
-235
| Closed | -$55K | – | 1259 |
|
|
2023
Q4 | $55K | Sell |
235
-49
| -17% | -$11.5K | ﹤0.01% | 982 |
|
|
2023
Q3 | $55K | Sell |
284
-47
| -14% | -$9.1K | ﹤0.01% | 982 |
|
|
2023
Q2 | $69K | Buy |
+331
| New | +$69K | ﹤0.01% | 1005 |
|
|
2021
Q4 | – | Sell |
-1,539
| Closed | -$635K | – | 1399 |
|
|
2021
Q3 | $635K | Sell |
1,539
-4,384
| -74% | -$1.81M | 0.01% | 453 |
|
|
2021
Q2 | $2.19M | Buy |
5,923
+1,425
| +32% | +$527K | 0.04% | 331 |
|
|
2021
Q1 | $1.3M | Buy |
4,498
+2,872
| +177% | +$832K | 0.02% | 338 |
|
|
2020
Q4 | $406K | Buy |
+1,626
| New | +$406K | 0.01% | 401 |
|